Drug firm Cipla Ltd.'s operating performance surpassed analyst estimates for the September ended quarter as margins expanded more than expected. Cipla reported a consolidated net profit of Rs 434.95 crore for the September quarter mainly on account of robust domestic sales. The company had posted a net profit of Rs 369.64 crore for the corresponding period of the previous fiscal. The Operating profit margins up by 155 bps YoY to 19.7% and the Operating profit increased by 18% YoY to Rs 804.39 crore. After the 316% increased in other income to Rs 113.33 crore, PBIDTA went up by 30% YoY to Rs 917.72crore....